Koconis John 4
4 · Timber Pharmaceuticals, Inc. · Filed Aug 22, 2023
Insider Transaction Report
Form 4
Koconis John
DirectorChief Executive Officer
Transactions
- Award
Common Stock, par value $0.001 per share
2023-08-20+70,385→ 70,785 total
Footnotes (1)
- [F1]On August 20, 2023, the Reporting Person was granted 70,385 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.001. 25% of the RSUs vest on August 20, 2024, and the remaining RSUs vest in 36 equal monthly installments beginning on September 20, 2024, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date; provided, however, that the RSUs will vest in full in the event that a "Change in Control" (as defined in the Issuer's 2020 Omnibus Incentive Plan) occurs while the Reporting Person remains in continuous service with the Issuer.